CXCL8 and neoplasm: determined that RNA-edited AZIN1 plays a significant role in the tumor vascular microenvironment and identifies IL-8 signaling, primarily through the application of small-molecule antagonists, such as reparixin, as a promising therapeutic target in hyper-edited cancer (91).